Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis — Stella

Home/Psychosis/

View on ClinicalTrials.gov

Recruiting

Back to Psychosis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Canada

Psychosis Intervention Early Recovery Program, St. John's, Newfoundland and Labrador

Nova Scotia Early Psychosis Program, Halifax, Nova Scotia

Key details

Phase

Post-approval study

Sponsor

Nova Scotia Health Authority

Collaborators

Dalhousie University

Enrollment target

~24 participants

Started

March 2025

Primary completion

August 2026

Age range

18 Years – 25 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.